Lenzings, Capital

Lenzing's Capital Question: A EUR 27 Million Alabama Bet Sits Alongside a EUR 136 Million Writedown

Published on 11/21/2026 at 11:51 | Editorial boerse-global.de
Goldman Sachs lowered its Lenzing holding to 4.90% as Berenberg cut its target to EUR 13.50, spotlighting returns on capital at Lenzing's sites.
Lenzing's Capital Question: A EUR 27 Million Alabama Bet Sits Alongside a EUR 136 Million Writedown Illustration mit AI erstellt.

Goldman Sachs trimmed its aggregate holding in Lenzing to 4.90% from 5.86%, with the threshold crossed on 13 November — a disclosure that landed the same week Berenberg cut its price target on the Austrian fibre maker from EUR 17.00 to EUR 13.50 while keeping a "Hold" rating. The stock fell 5.9% on Friday and has shed 15% over seven trading days.

Those moves frame a question that neither the investment total nor the impairment charges can answer on their own: what return can Lenzing earn on the capital it deploys at each of its sites?

Two Numbers, Two Different Things

On 12 November Lenzing announced a EUR 27 million investment to expand specialty fibre capacity for nonwoven applications in Mobile, Alabama — part of a broader EUR 50 million programme for the nonwovens business. The figure describes where the company is putting capital. It says nothing about what that capital will earn.

An impairment works in the opposite direction. It concerns money already sunk into a site and corrects a carrying value; it is not equivalent to a cash outflow of the same size. Berenberg folded EUR 136 million of writedowns for Grimsby and Heiligenkreuz into its 2026 earnings-per-share forecast. That sum covers both plants, so it cannot be attributed to Heiligenkreuz alone, nor used as a yardstick for a possible sale price. Nor can the Alabama expansion be netted against writedowns elsewhere — one is a deployment decision, the other a revaluation of existing assets.

Should investors sell immediately? Or is it worth buying Lenzing?

Heiligenkreuz Is the Next Hurdle

Lenzing aims to have clarity on a viable sale solution for Heiligenkreuz by the end of 2026. Failing that, closure is scheduled for the end of the first quarter of 2027. A potential sale and a planned shutdown are distinct scenarios, not steps already taken.

Should a workable sale be found, the wider restructuring becomes easier to assess — though the terms of any deal would matter more than its mere existence. A sale would not, by itself, prove that the US expansion pays off. If no buyer emerges, the closure path becomes the benchmark; it might reduce uncertainty about the plant's future without shedding any light on what the added capacity in Mobile can contribute to earnings.

What the Target Cut Does and Doesn't Say

Berenberg's unchanged "Hold" rating should not obscure the fact that the broker now values the shares lower. Equally, the cut cannot be decomposed to show how much each of the two writedowns contributed. The target applies to the stock, not to any single site.

The distinction is the heart of the matter. Writedowns signal that previous carrying values have been marked down. Mobile is a decision about where Lenzing puts capital. Whether that produces more value for shareholders will be settled by the returns on that outlay, not by the size of the cheque.

The next hard date is the end of 2026, when Lenzing is due to clarify Heiligenkreuz's future. Investors will be watching whether the company can name a credible path for the plant — a development that would make the site question more tangible without prejudging the commercial test still ahead in Alabama.

Ad

Lenzing Stock: New Analysis - 21 November

Fresh Lenzing information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Lenzing analysis...

Disclaimer...
en | AT0000644505 | LENZINGS | boerse | 70542249 |